Third Harmonic Bio, Inc.
DelistedCIK 1923840fmd_0EAMBFVYWVPZ9AE33826SPC699Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2021 to Mar 31, 2025, 17 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Net interest income | – | 3 | 13 | 13 |
| Research and development | 16 | 24 | 24 | 37 |
| Total operating expenses | 19 | 38 | 44 | 59 |
| Operating income | (19) | (38) | (44) | (59) |
| Other non-operating income (expense) | (11) | 3 | 13 | 13 |
| Income before taxes | (30) | (35) | (31) | (45) |
| Net income | (30) | (35) | (31) | (45) |
| Net income to common shareholders | (30) | 35 | 31 | 45 |